AKT1 and neoplasm: Fourteen days after inoculation of tumor cells, Akt-i group was treated with 20 mg/kg intraperitoneal injection of Akt inhibitor (GSK690693) for 5 times, once a day (2 days off for 2 days), and other groups were given the equal volume of solvent.